drugset / Trial / NCT07043686

Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study

NCT07043686

Recruiting 30 enrolled University Medical Centre Ljubljana
Non-randomizedParallel-groupSingle-blindTreatment

Summary

The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.

Timeline

Start
2025-06-13
Primary completion
2027-07-15
Completion
2027-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cerebrolysin Peptide 30 ml Intravenous

Indications